We showed that in prostate cancer patients before therapy both the adaptive immune system (altered CD4+ Teff cells and increased fraction of Tregs with suppressive phenotype) and the innate immune system (decreased NK cell fraction) were altered. This evidence concerns the gene CD4 and Familial prostate cancer.